Opioid Use Disorder
Cessation Therapeutics Inc. focuses on clinical research in opioid use disorder, with particular attention to the respiratory complications associated with fentanyl exposure and opioid-induced respiratory depression.
- Fentanyl-related respiratory effects
- Ventilatory response assessment
- Opioid safety in people with OUD
The sponsor’s current research activity is centered on understanding how opioid exposure affects breathing control in both healthy adults and participants with opioid use disorder.
Respiratory Physiology
The funded trial examines changes in minute ventilation and respiratory depression, placing pulmonary function and breathing regulation at the core of the sponsor’s clinical interests.
- Minute ventilation
- Breathing control
- Respiratory safety
Research activity in this area reflects a therapeutic interest in how opioid-related exposure influences ventilatory drive and respiratory stability.
Substance Use and Dependence
Clinical work supported by the sponsor is directly aligned with the treatment landscape for substance use disorders, especially conditions involving opioid dependence and the medical risks tied to illicit and synthetic opioids.
- Opioid dependence
- Synthetic opioid exposure
- Clinical management of OUD
This area connects addiction medicine with the evaluation of physiological outcomes relevant to patient safety.
Healthy Volunteers and Patient Populations
The sponsor’s trial includes both healthy adult participants and individuals with opioid use disorder, indicating interest in comparing respiratory responses across distinct clinical populations.
- Healthy adult physiology
- Participant comparison
- Cross-population respiratory assessment
This design supports evaluation of how opioid-related respiratory effects may differ between controlled and affected populations.
